Literature DB >> 29131485

In Vitro Effects of Serotonin, Melatonin, and Other Related Indole Compounds on Amyloid-β Kinetics and Neuroprotection.

Ruth Hornedo-Ortega1, Grégory Da Costa2, Ana B Cerezo1, Ana M Troncoso1, Tristan Richard2, M Carmen Garcia-Parrilla1.   

Abstract

SCOPE: Amyloid-β peptide is the main component of senile plaques in Alzheimer's disease. The inhibition of amyloid-β peptide assembly, the destabilization of amyloid-β peptide aggregates, and the decrease of its cytotoxicity for the prevention of neuronal death are considered neuroprotective effects. In this work, the protective effects against amyloid-β peptide aggregation and cytotoxicity of eight indolic compounds are evaluated: tryptophan, tryptamine, serotonin, tryptophol, N-acetylserotonin, 3-indoleacetic acid, tryptophan ethyl ester, and melatonin. METHODS AND
RESULTS: Thioflavin T spectroscopic assay, transmission electron microscopy, western blotting, circular dichroism, NMR, cell viability (thiazolyl blue tetrazolium bromide assay), quantitative PCR, and heme oxygenase activity are used. Serotonin is the most effective compound for inhibiting amyloid-β peptide aggregation. Almost all the indolic compounds tested prevent amyloid-β peptide-induced and increase cell viability, being between 9 and 25%. Melatonin and serotonin are the most active. Moreover, serotonin increased the expression of SIRT-1 and 2, heat shock protein 70, and heme oxygenase activity, this being a possible mechanism underlying the observed neuroprotective effect.
CONCLUSION: Melatonin and other related indolic compounds, mainly serotonin, show an inhibitory and destabilizing effect on amyloid-β peptide fibril formation and they possess neuroprotective properties related to the vitagenes system.
© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  amyloid-β; fibril formation; indolic; neuroprotection; vitagene system

Mesh:

Substances:

Year:  2018        PMID: 29131485     DOI: 10.1002/mnfr.201700383

Source DB:  PubMed          Journal:  Mol Nutr Food Res        ISSN: 1613-4125            Impact factor:   5.914


  7 in total

1.  A simple in vitro assay for assessing the efficacy, mechanisms and kinetics of anti-prion fibril compounds.

Authors:  Carol L Ladner-Keay; Li Ross; Rolando Perez-Pineiro; Lun Zhang; Trent C Bjorndahl; Neil Cashman; David S Wishart
Journal:  Prion       Date:  2018-10-09       Impact factor: 3.931

Review 2.  EDR Peptide: Possible Mechanism of Gene Expression and Protein Synthesis Regulation Involved in the Pathogenesis of Alzheimer's Disease.

Authors:  Vladimir Khavinson; Natalia Linkova; Ekaterina Kozhevnikova; Svetlana Trofimova
Journal:  Molecules       Date:  2020-12-31       Impact factor: 4.411

3.  Alteration of Metabolic Profile and Potential Biomarkers in the Plasma of Alzheimer's Disease.

Authors:  Yaping Shao; Yang Ouyang; Tianbai Li; Xinyao Liu; Xiaojiao Xu; Song Li; Guowang Xu; Weidong Le
Journal:  Aging Dis       Date:  2020-12-01       Impact factor: 6.745

Review 4.  Serotonin 2 Receptors, Agomelatine, and Behavioral and Psychological Symptoms of Dementia in Alzheimer's Disease.

Authors:  Hui-Hua Li; Xiao-Yan Yao; Sheng Tao; Xue Sun; Pan-Pan Li; Xi-Xin Li; Zhu-Li Liu; Chao Ren
Journal:  Behav Neurol       Date:  2021-03-31       Impact factor: 3.342

5.  How mind-body therapies might reduce pathological features of Alzheimer's disease.

Authors:  Melanie Huttenrauch; Susana Castro-Obregón
Journal:  Neural Regen Res       Date:  2022-08       Impact factor: 5.135

6.  Serotonin Promotes Serum Albumin Interaction with the Monomeric Amyloid β Peptide.

Authors:  Ekaterina A Litus; Alexey S Kazakov; Evgenia I Deryusheva; Ekaterina L Nemashkalova; Marina P Shevelyova; Aliya A Nazipova; Maria E Permyakova; Elena V Raznikova; Vladimir N Uversky; Sergei E Permyakov
Journal:  Int J Mol Sci       Date:  2021-05-31       Impact factor: 5.923

Review 7.  Role of Indole Scaffolds as Pharmacophores in the Development of Anti-Lung Cancer Agents.

Authors:  Jyothi Dhuguru; Rachid Skouta
Journal:  Molecules       Date:  2020-04-01       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.